This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Academia Sinica, Other. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 726 
1 out of 834,453 Years Active: 2022-2023
Title: Innovations of Cheng-Bang Jian in Liposome Technology
Introduction
Cheng-Bang Jian is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of synthetic polypeptides and their applications in liposome technology. With a total of 2 patents, his work focuses on innovative methods for drug delivery and disease treatment.
Latest Patents
Cheng-Bang Jian's latest patents include groundbreaking research on liposomes and their uses. One of his patents discloses novel synthetic polypeptides that are instrumental in the preparation of liposomes. The synthetic polypeptide comprises a membrane lytic motif, a masking motif, and a linker that connects these two motifs. This linker is designed to be cleavable by various stimuli, such as light, protease, or phosphatase. Upon exposure to the stimulus, the linker separates the masking motif from the membrane lytic motif, which activates the membrane lytic activity on the liposome. This process leads to the collapse of the liposome's structure, allowing for the release of the encapsulated agent at the target site. Additionally, the patent outlines methods for diagnosing or treating diseases using these innovative liposomes.
Career Highlights
Cheng-Bang Jian has worked with prestigious institutions, including Academia Sinica, where he has furthered his research in the field of synthetic polypeptides and liposome technology. His work has garnered attention for its potential applications in medical treatments and drug delivery systems.
Collaborations
Throughout his career, Cheng-Bang Jian has collaborated with esteemed colleagues, including Jia-Lin Hong and Hsien-Ming Lee. These collaborations have contributed to the advancement of research in liposome technology and synthetic polypeptides.
Conclusion
Cheng-Bang Jian's innovative work in liposome technology and synthetic polypeptides showcases his significant contributions to the field. His patents reflect a commitment to advancing medical science and improving treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile